研究目的
To develop and evaluate functionalized carbon nanomaterials, specifically graphene and nanodiamond, for use in drug delivery systems for cancer therapy, including phototherapy, chemotherapy, and gene therapy.
研究成果
Functionalized carbon nanomaterials, specifically graphene and nanodiamond, show promise as effective drug carriers for cancer therapy. The graphene-Ce6 composite exhibits high drug loading capacity and efficient phototherapeutic effects, while polyglycerol-functionalized nanodiamond conjugated with platinum drugs or DNA demonstrates targeted cytotoxicity and gene delivery capabilities. Further in vivo studies are needed to optimize and validate these nanodrugs for clinical applications.
研究不足
The study is limited to in vitro evaluations; in vivo applications are not covered. The dispersibility of some functionalized nanodiamonds decreases after conjugation, potentially affecting stability. The mechanisms of drug release and cellular uptake require further investigation for optimization.
1:Experimental Design and Method Selection:
The study involves the synthesis and functionalization of graphene and nanodiamond through chemical methods such as liquid-phase exfoliation, ring-opening polymerization, and click chemistry to create nanodrug composites. Characterization techniques include AFM, STEM, absorption and fluorescence spectroscopy, Raman spectroscopy, FTIR, NMR, DLS, zeta potential measurements, and biological assays like cell viability tests and FACS analysis.
2:Sample Selection and Data Sources:
Samples include graphite for graphene exfoliation, nanodiamond particles (50 nm size), chlorin e6 (Ce6), cisplatin, RGD peptide, basic polypeptides (Arg8, Lys8, His8), and plasmid DNA. Data are derived from experimental measurements and comparisons with controls.
3:List of Experimental Equipment and Materials:
Equipment includes bath-sonicator, centrifuge, AFM, STEM, spectrophotometer, fluorometer, Raman spectrometer, FTIR spectrometer, NMR spectrometer, DLS instrument, zeta potential analyzer, ICP-AES, and cell culture facilities. Materials include graphite, Ce6, glycidol, tosyl chloride, sodium azide, succinic anhydride, RGD peptide, cisplatin, basic polypeptides, and cell lines (HeLa, U87MG).
4:Experimental Procedures and Operational Workflow:
For graphene-Ce6 composite: exfoliate graphite with Ce6 using sonication, centrifuge to separate, characterize with AFM, STEM, spectroscopy, and evaluate drug release and cell toxicity. For nanodiamond composites: functionalize with polyglycerol, conjugate with drugs or peptides via chemical reactions, characterize with FTIR, NMR, DLS, and assess cytotoxicity and cellular uptake.
5:Data Analysis Methods:
Data are analyzed using statistical methods (e.g., Student's t-test for cell viability), spectroscopic peak analysis, and calculation of concentrations and loading capacities based on extinction coefficients.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容-
Atomic Force Microscope
Used to image and measure the thickness of graphene sheets in the G-Ce6 dispersion.
-
Scanning Transmission Electron Microscope
Used to observe the transparency and structure of exfoliated graphene sheets.
-
Raman Spectrometer
Used to characterize the structure of graphene through D-, G-, and G'-bands.
-
Fourier Transform Infrared Spectrometer
Used to analyze functional groups on nanodiamond derivatives.
-
Nuclear Magnetic Resonance Spectrometer
Used for solution-phase characterization of nanodiamond derivatives.
-
Dynamic Light Scattering Instrument
Used to measure hydrodynamic diameters of nanoparticles.
-
Zeta Potential Analyzer
Used to measure surface charge of nanoparticles.
-
Inductively Coupled Plasma-Atomic Emission Spectrometer
Used to estimate platinum content in nanodiamond composites.
-
Fluorescence Activated Cell Sorter
Used to evaluate cellular uptake of Ce6 by HeLa cells.
-
Centrifuge
Used to separate supernatants after exfoliation and centrifugation.
-
Bath-Sonicator
Used for liquid-phase exfoliation of graphite with Ce6.
-
登录查看剩余9件设备及参数对照表
查看全部